Shree Pacetronix Reports Robust Q2 FY26 Performance with 187% Profit Surge

Shree Pacetronix Limited , a player in the life-saving devices segment, has reported a stellar performance for the second quarter of fiscal year 2026. The company's financial results, approved by its Audit Committee and Board of Directors on November 1, 2025, showcase significant growth in both revenue and profitability.

Key Financial Highlights

Particulars (in Rs. Lakhs)	Q2 FY26	Q2 FY25	YoY Change
Revenue from Operations	658.18	404.40	62.76%
Net Profit	187.88	2.95	6267.46%
Earnings Per Share (Rs.)	5.22	0.08	6425.00%

Revenue Growth

Shree Pacetronix witnessed a robust 62.76% year-on-year increase in revenue from operations, which stood at Rs. 658.18 lakhs for the quarter ended September 30, 2025, compared to Rs. 404.40 lakhs in the corresponding quarter of the previous year.

Profitability Surge

The company's bottom line saw an exceptional improvement, with net profit soaring to Rs. 187.88 lakhs, a remarkable 6267.46% increase from Rs. 2.95 lakhs in the same quarter last year. This substantial growth in profitability underscores the company's operational performance during the quarter.

Half-Yearly Performance

For the half-year period ended September 30, 2025:

Revenue reached Rs. 1,194.49 lakhs, up from Rs. 889.52 lakhs in the previous year.
Net profit stood at Rs. 198.68 lakhs, compared to Rs. 40.48 lakhs in the corresponding period.

Earnings Per Share

The company's earnings per share (EPS) for Q2 FY26 increased significantly to Rs. 5.22, compared to Rs. 0.08 in the same period last year, reflecting the strong bottom-line growth.

Management Approval

The financial results were reviewed and approved by the Audit Committee and subsequently by the Board of Directors in their meeting held on November 1, 2025.

Shree Pacetronix's quarterly performance indicates a positive trajectory in its operations within the life-saving devices segment. The substantial growth in revenue and profitability may be attributed to various factors such as increased market demand, operational efficiencies, or strategic initiatives undertaken by the company.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	+3.15%	+18.41%	+278.57%	+111.92%	+2,222.52%

Shree Pacetronix Limited , a leading cardiac pacing devices manufacturer, has disclosed the receipt of a pre-offer advertisement for an open offer that could potentially reshape its ownership structure. The open offer, made by Akash Sethi as the Acquirer, along with Atul Kumar Sethi, Amita Sethi, and Ashish Sethi as Persons Acting in Concert (PACs), aims to acquire up to 9,75,000 equity shares, representing 26% of the expanded share capital from public shareholders.

Key Details of the Open Offer

Item	Detail
Offer Price	Rs. 100.00 per equity share, payable in cash
Tendering Period	October 25, 2025, to November 14, 2025
Shares Sought	Up to 9,75,000 equity shares (26% of expanded share capital)
Acquirer	Akash Sethi
Persons Acting in Concert	Atul Kumar Sethi, Amita Sethi, and Ashish Sethi

Regulatory Compliance and Recommendations

The open offer is being made under Regulation 3(1) of SEBI SAST Regulations, following a triggering acquisition. The Committee of Independent Directors has recommended the offer as fair and reasonable. However, public shareholders are advised to independently evaluate the offer and make an informed decision.

Financial Advisors

Manager to the Offer: Vivro Financial Services Private Limited
Registrar to the Offer: MUFG Ittehad India Private Limited

This development comes as part of the ongoing consolidation in the medical devices sector, potentially strengthening Shree Pacetronix's position in the cardiac pacing market. Shareholders are encouraged to review the detailed offer documents and seek independent financial advice before making a decision.

The outcome of this open offer could have significant implications for Shree Pacetronix's future strategic direction and market positioning. Investors and industry observers will be closely watching the developments as they unfold.